Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?
{{output}}
The current standard of care for elderly patients with newly diagnosed multiple myeloma is melphalan and prednisone (MP) in combination with either bortezomib (VMP) or thalidomide (MPT), with lenalidomide plus dexamethasone increasingly being employed. The add... ...
